Journal of Nanomedicine & Nanotechnology

MPH, Clinical and Public Health Researcher, Cardiac Implants LLCNew York University, New York, USA

Biography

Porter TR is affiliated to MPH, Clinical and Public Health Researcher. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.
 

Publications

• Prospective   
  Targeted Site-Specific Therapeutics for COVID-19
  Author(s): Iversen P, Porter TR and Kipshidze N*
  
  No definitive therapies for COVID-19 have yet to be identified. The several hundred planned or ongoing clinical trials globally will provide some insights into therapies that may or may not work. The overwhelming majority of therapeutics relies on the systemic delivery of drugs; however, COVID-19 is largely localized to the lungs with some subgroups afflicted in other organ systems. We propose the use of a targeted drug delivery approach in which therapeutics can be delivered using engineered delivery vehicles to reach damaged lung tissue directly. .. View more»
  

  DOI: 10.35248/2157-7439.20.11.548

  Abstract HTML PDF